HRT Financial LP Purchases Shares of 134,649 Hamilton Lane Inc. $HLNE

HRT Financial LP bought a new stake in Hamilton Lane Inc. (NASDAQ:HLNE) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 134,649 shares of the company’s stock, valued at approximately $19,136,000. HRT Financial LP owned 0.25% of Hamilton Lane as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Kayne Anderson Rudnick Investment Management LLC acquired a new position in shares of Hamilton Lane in the 1st quarter worth approximately $432,772,000. Champlain Investment Partners LLC bought a new stake in shares of Hamilton Lane during the first quarter valued at approximately $112,887,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of Hamilton Lane by 63.4% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company’s stock valued at $189,555,000 after purchasing an additional 494,637 shares in the last quarter. Norges Bank bought a new position in Hamilton Lane in the 2nd quarter valued at $46,641,000. Finally, Nuveen LLC acquired a new stake in shares of Hamilton Lane in the 1st quarter valued at $24,334,000. Institutional investors and hedge funds own 97.40% of the company’s stock.

Insider Buying and Selling at Hamilton Lane

In related news, CEO Juan Delgado-Moreira bought 8,000 shares of the company’s stock in a transaction on Friday, November 7th. The stock was acquired at an average cost of $130.35 per share, for a total transaction of $1,042,800.00. Following the completion of the transaction, the chief executive officer directly owned 1,314,447 shares in the company, valued at $171,338,166.45. This trade represents a 0.61% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 22.21% of the company’s stock.

Hamilton Lane Trading Down 2.3%

Shares of Hamilton Lane stock opened at $130.19 on Friday. The company’s 50-day moving average price is $123.30 and its 200-day moving average price is $140.15. The company has a market cap of $7.26 billion, a price-to-earnings ratio of 23.59 and a beta of 1.33. Hamilton Lane Inc. has a 12-month low of $111.98 and a 12-month high of $179.19. The company has a current ratio of 3.49, a quick ratio of 3.49 and a debt-to-equity ratio of 0.25.

Hamilton Lane (NASDAQ:HLNE) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.54 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.46. Hamilton Lane had a net margin of 31.12% and a return on equity of 29.43%. The firm had revenue of $190.88 million for the quarter, compared to analysts’ expectations of $171.86 million. On average, equities analysts expect that Hamilton Lane Inc. will post 4.97 earnings per share for the current fiscal year.

Hamilton Lane Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Friday, December 19th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Friday, December 19th. This represents a $2.16 annualized dividend and a dividend yield of 1.7%. Hamilton Lane’s payout ratio is presently 39.13%.

Analyst Upgrades and Downgrades

Several brokerages have commented on HLNE. Keefe, Bruyette & Woods upped their target price on shares of Hamilton Lane from $150.00 to $158.00 and gave the company an “outperform” rating in a research note on Thursday, November 6th. Zacks Research downgraded Hamilton Lane from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 22nd. Wall Street Zen raised Hamilton Lane from a “sell” rating to a “hold” rating in a research report on Sunday, November 9th. The Goldman Sachs Group raised Hamilton Lane from a “neutral” rating to a “buy” rating and set a $165.00 target price on the stock in a report on Thursday, November 6th. Finally, UBS Group assumed coverage on Hamilton Lane in a research note on Thursday. They set a “buy” rating and a $166.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $160.13.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.